PMV Pharmaceuticals

PMVP • NASDAQ • Stock Fundamentals

PMV Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David H. Mack, with a market cap of $65.6M.

Market Cap$65.6M

Employees63.0

CEODavid H. Mack

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 12, 2026 · 16 days agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about PMV Pharmaceuticals

PMV Pharmaceuticals (PMVP) has a market capitalization of $65.6M and trades on NASDAQ.

PMV Pharmaceuticals has approximately 63 employees.